company

Genentech, Inc.

as of 2026-07-01
Monitor thisAsk about this
at a glance
2 trials sponsored · 4 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

4 assets
Ocrelizumab infusionPhysical and neuro-cognitive evaluationsPsychosis and cognitive assessmentsSafety labs and electrocardiogram

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Ocrelizumab infusion
BIOLOGICAL
drug
Physical and neuro-cognitive evaluations
BEHAVIORAL
drug
Psychosis and cognitive assessments
BEHAVIORAL
drug
Safety labs and electrocardiogram
DIAGNOSTIC_TEST
drug